SEK 255
Key Takeaways
Risk factor
Meaningful price volatility
Profitability factor
Favourable analyst view
About
RaySearch Laboratories AB (publ), a medical technology company, develops software solutions for cancer treatment worldwide. It develops and markets RayStation, a treatment planning system for treatment activities, such as automated planning, adaptive therapy, multi-criteria optimization, fast and accurate dose computations, OAR dose reduction, robustness, machine learning, VMAT, IMRT, 3D-CRT, virtual simulation, electron beam therapy, tomotherapy,...
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EB
Target Price
The average target price of RAY-B.ST is 367 and suggests 44% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc
